BioMaxima S.A. (FRA:944)

Market Cap	12.38M
Revenue (ttm)	13.45M
Net Income (ttm)	165.49K
Shares Out	n/a
EPS (ttm)	0.04
PE Ratio	74.83
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	2.520
Previous Close	2.490
Day's Range	2.420 - 2.530
52-Week Range	2.120 - 3.180
Beta	n/a
RSI	38.08
Earnings Date	Nov 28, 2025

About BioMaxima

BioMaxima S.A. manufactures and distributes microbiological media, reagents, and equipment for in vitro diagnostics in Poland. Its primary products include analyzers and diagnostic reagents for testing the biochemical parameters of blood and other body fluids; systems for the determination of drug resistance of microorganisms; quick diagnostic tests for detecting infectious diseases, cancer markers, heart attack markers, and addictive substances and readers; urine analysis systems; hematology analyzers and reagents; ionselective analyzers and r...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1997
• Employees: 126
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 944

Financial Performance

In 2024, BioMaxima's revenue was 52.85 million, an increase of 12.96% compared to the previous year's 46.79 million. Earnings were 535,000, a decrease of -8.70%.

Financial numbers in PLN